Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
CENA AKCJI
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionCerity Partners LLC
Latest Disclosed Ownership329,910 shares
Latest Disclosed Value $ 50,392,662
Cerity Partners LLC reports 11.92% increase in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On May 15, 2026 - Cerity Partners LLC filed a 13F-HR form disclosing ownership of 329,910 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $42,393,435 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 294,770 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 11.92% during the quarter. The current value of the position is $39,919,110 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 329,910 35,140 11.92 50,393 24.00 0.0354
2026-02-11 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 294,770 -37,912 -11.40 40,641 -4.74 0.0592
2025-10-22 2025-09-30 13F NOVARTIS COM 66987V109 332,682 -6,073 -1.79 42,663 4.08 0.0692
2025-08-13 2025-06-30 13F NOVARTIS ADR 66987V109 338,755 1,382 0.41 40,993 8.86 0.0731
2025-04-30 2025-03-31 13F NOVARTIS Stock 66987V109 337,373 26,884 8.66 37,656 21.43 0.0763
2025-02-13 2024-12-31 13F NOVARTIS Stock 66987V109 310,489 -4,999 -1.58 31,010 -14.54 0.0673
2024-11-12 2024-09-30 13F NOVARTIS Stock 66987V109 315,488 46,232 17.17 36,287 26.59 0.0803
2024-08-13 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 269,256 -17,920 -6.24 28,665 1.89 0.0755
2024-05-14 2024-03-31 13F NOVARTIS COM 66987V109 287,176 39,375 15.89 28,133 12.44 0.0743
2024-01-26 2023-12-31 13F NOVARTIS COM 66987V109 247,801 58,395 30.83 25,021 29.69 0.0822
2023-11-14 2023-09-30 13F NOVARTIS ADR 66987V109 189,406 -38,567 -16.92 19,293 -16.14 0.0938
2023-08-14 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 227,973 3,446 1.53 23,005 -7.43 0.0896
2023-05-11 2023-03-31 13F NOVARTIS COM 66987V109 224,527 156,290 229.04 24,852 255.83 0.0586
2023-02-15 2022-12-31 13F NOVARTIS ADR 66987V109 68,237 28,376 71.19 6,984 130.42 0.0447
2022-11-14 2022-09-30 13F NOVARTIS COM 66987V109 39,861 1,142 2.95 3,031 -7.39 0.0364
2022-08-10 2022-06-30 13F NOVARTIS COM 66987V109 38,719 14,764 61.63 3,273 77.01 0.0362
2022-04-25 2022-03-31 13F NOVARTIS COM 66987V109 23,955 1,125 4.93 1,849 -7.27 0.0287
2022-02-14 2021-12-31 13F NOVARTIS Stock 66987V109 22,830 9,957 77.35 1,994 89.36 0.0303
2021-10-25 2021-09-30 13F Novartis AG F Sponsored ADR Stock 66987V109 12,873 -693 -5.11 1,053 -14.94 0.0232
2021-08-11 2021-06-30 13F NOVARTIS Stock 66987V109 13,566 -1,303 -8.76 1,238 -2.60 0.0271
2021-08-11 2021-03-31 13F/A-1 NOVARTIS Stock 66987V109 14,869 -1,840 -11.01 1,271 -19.46 0.0302
2021-05-12 2021-03-31 13F NOVARTIS Stock 66987V109 15,192 -1,517 1,299 0.0385
2021-02-11 2020-12-31 13F NOVARTIS Stock 66987V109 16,709 -780 -4.46 1,578 3.75 0.0506
2020-11-12 2020-09-30 13F NOVARTIS COM 66987V109 17,489 939 5.67 1,521 5.26 0.0626
2020-08-17 2020-06-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 16,550 -2,259 -12.01 1,445 -6.83 0.0798
2020-08-14 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 16,805 -2,004 1,467 80,908.5584
2020-05-14 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 18,809 -731 -3.74 1,551 -16.21 0.0977
2020-02-14 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 19,540 -2,012 -9.34 1,851 -1.17 0.0944
2019-10-30 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 21,552 2,659 14.07 1,873 8.52 0.1099
2019-08-14 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 18,893 -7,823 -29.28 1,726 -32.79 0.1088
2019-05-14 2019-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 26,716 -7,900 -22.82 2,568 -13.54 0.1729
2019-02-06 2018-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 34,616 767 2.27 2,970 1.85 0.1989
2018-11-15 2018-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 33,849 587 1.76 2,916 16.04 0.2020
2018-08-15 2018-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 33,262 -1,261 -3.65 2,513 -9.96 0.1857
2018-05-15 2018-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 34,523 -7,340 -17.53 2,791 -20.60 0.2134
2018-02-14 2017-12-31 13F Novartis AG Sp ADR SPONSORED ADR 66987V109 41,863 3,494 9.11 3,515 6.71 0.2359
2017-11-13 2017-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 38,369 2,965 8.37 3,294 11.47 0.2332
2017-08-10 2017-06-30 13F Novartis AG Sp ADR SPONSORED ADR 66987V109 35,404 2,518 7.66 2,955 21.01 0.2475
2017-05-02 2017-03-31 13F Novartis AG Sp ADR ADR 66987V109 32,886 11,689 55.14 2,442 58.16 0.2039
2017-02-13 2016-12-31 13F NOVARTIS A G COM 66987V109 21,197 21,197 1,544 2.1248
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.